This summary was created by AI, based on 1 opinions in the last 12 months.
The experts' reviews of the BMO Floating Rate Hi Yield ETF (ZFH-T) suggest that it may not be a good option for investors, especially in the event of a recession. They caution against purchasing this stock due to its lack of defensive qualities and the complexity of its products, which may not be suitable for the average investor.
4.9% yield. Holds exposure to a high yield index so you get a high yield return. There are risks. It is very similar to the volatility of the market.
Floating rate gives you the resetability when interest rates change. It is a good way to mitigate the downside when interest rates change, although he does not see them changing over the next year or so. You are getting a lower return on this one as well. There are a lot of pros and cons – it depends on the investor’s situation.
Floating rate high yield. Chart is almost flat. You are waiting for central banks. You will wait for another year. It is dead money for a while.
BMO Floating Rate Hi Yield ETF is a Canadian stock, trading under the symbol ZFH-T on the Toronto Stock Exchange (ZFH-CT). It is usually referred to as TSX:ZFH or ZFH-T
In the last year, 1 stock analyst published opinions about ZFH-T. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for BMO Floating Rate Hi Yield ETF.
BMO Floating Rate Hi Yield ETF was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for BMO Floating Rate Hi Yield ETF.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of BMO Floating Rate Hi Yield ETF published on Stockchase.
On 2024-11-15, BMO Floating Rate Hi Yield ETF (ZFH-T) stock closed at a price of $15.02.
Not a good option if we head into recession. Would not recommend buying. Not a good defensive name. Products are too complex for average investor.